Drug eruptions in children

Current Problems in Dermatology

Volumn 14, Issue 5, 2002, Pages 153-182

  Shin, Helen T ^a   Chang, Mary Wu ^a   Callen, Jeffrey P ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BLEOMYCIN; CAPTOPRIL; CARBAMAZEPINE; CEPHALOSPORIN DERIVATIVE; CETIRIZINE; CHLORPROMAZINE; CORTICOSTEROID; COTRIMOXAZOLE; CYPROHEPTADINE; DIPHENHYDRAMINE; DOXEPIN; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYZINE; LORATADINE; MACROLIDE; NALIDIXIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PHENYTOIN; PIROXICAM; STEROID; SULFONAMIDE; UNINDEXED DRUG;

ACNE; ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; CHILD; CLINICAL FEATURE; DESENSITIZATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG ERUPTION; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM; ERYTHRODERMA; HISTOPATHOLOGY; HUMAN; PATIENT EDUCATION; PETECHIA; PHOTOSENSITIVITY REACTION; PRURITUS; PSEUDOPORPHYRIA; PURPURA; PUSTULOSIS; RASH; REVIEW; RISK FACTOR; SERUM SICKNESS LIKE REACTION; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; URTICARIA;

EID: 0038064479     PISSN: 10400486     EISSN: None     Source Type: Journal    
DOI: 10.1067/mdm.2002.128942     Document Type: Review

References (191)

1. KSS Alanko K Kauppinen Cutaneous drug reactions: clinical types and causative agents. A five-year survey of inpatients (1981-1985) Acta Derm Venereol 69 1989 223 226
2. J Litt Drug eruption reference manual 2000 Parthenon Publishing Group New York
3. MS Kramer JM Leventhal TA Hutchinson AR Feinstein An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use JAMA 242 1979 623 632
4. A Cirko-Begovic B Vrhovac I Bakran Intensive monitoring of adverse drug reactions in infants and preschool children Eur J Clin Pharmacol 36 1989 63 65
5. EO Ibia RH Schwartz BL Wiedermann Antibiotic rashes in children: a survey in a private practice setting Arch Dermatol 136 2000 849 854
6. SR Knowles LE Shapiro NH Shear Anticonvulsant hypersensitivity syndrome: incidence, prevention and management Drug Saf 21 1999 489 501
7. M Bigby S Jick H Jick K Arndt Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982 JAMA 256 1986 3358 3363
8. KK Zürcher Adverse drug reactions. Cutaneous drug reactions: an integral synopsis of today`s systemic drugs 1980 (Switzerland): Karger Basel 1-10
9. PJ Bayard TG Berger MA Jacobson Drug hypersensitivity reactions and human immunodeficiency virus disease J Acquir Immune Defic Syndr 5 1992 1237 1257
10. C Verhagen LJ Stalpers BE de Pauw C Haanen Drug-induced skin reactions in patients with acute non-lymphocytic leukaemia Eur J Haematol 38 1987 225 230
11. SJ Chanock LM Luginbuhl K McIntosh SE Lipshultz Life-threatening reaction to trimethoprim/sulfamethoxazole in pediatric human immunodeficiency virus infection Pediatrics 93 1994 519 521
12. FM Gordin GL Simon CB Wofsy J Mills Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome Ann Intern Med 100 1984 495 499
13. PC Gell RRA Coombs Classification of allergic reactions responsible for clinical hypersensitivity and disease PGH Gell RRA Coombs PJ Lachmann Clinical aspects of immunology 1975 Blackwell Oxford 761 781
14. JA Anderson NF Adkinson Allergic reactions to drugs and biologic agents JAMA 258 1987 2891 2899
15. M Boguniewicz DY Leung Hypersensitivity reactions to antibiotics commonly used in children Pediatr Infect Dis J 14 1995 221 231
16. JA Anderson Allergic reactions to drugs and biological agents JAMA 268 1992 2844 2857
17. JD Bernhard RS Berman DL Silvestri Maculopapularism Am J Dermatopathol 8 1986 173 174
18. AN Crowson CM Magro Recent advances in the pathology of cutaneous drug eruptions Dermatol Clin 17 1999 537 560
19. V Legrain A Taieb T Sage J Maleville Urticaria in infants: a study of forty patients Pediatr Dermatol 7 1990 101 107
20. E Bonifazi CL Meneghini A Ceci Pathogenetic factors in urticaria in children. A clinico-experimental study Dermatologica 154 1977 65 72
21. FJ Twarog Urticaria in childhood: pathogenesis and management Pediatr Clin North Am 30 1983 887 898
22. P Mortureux C Leaute-Labreze V Legrain-Lifermann T Lamireau J Sarlangue A Taieb Acute urticaria in infancy and early childhood: a prospective study Arch Dermatol 134 1998 319 323
23. CMP Leaute-Labreze A Taieb Urticaria JOA Harper N Prose Textbook of Pediatr Dermatol Vol 1 2000 Blackwell Science London 587 599
24. CD Kennard CN Ellis Pharmacologic therapy for urticaria J Am Acad Dermatol 25 1991 176 187 discussion 188-9
25. VK Sharma S Dhar Clinical pattern of cutaneous drug eruption among children and adolescents in north India Pediatr Dermatol 12 1995 178 183
26. SH Sicherer HA Sampson Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management J Allergy Clin Immunol 104 1999 S114 122
27. K Kauppinen K Juntunen H Lanki Urticaria in children. Retrospective evaluation and follow-up Allergy 39 1984 469 472
28. A Harris FJ Twarog RS Geha Chronic urticaria in childhood: natural course and etiology Ann Allergy 51 1983 161 165
29. PD van der Linden J van der Lei AE Vlug BH Stricker Skin reactions to antibacterial agents in general practice J Clin Epidemiol 51 1998 703 708
30. M Hide DM Francis CE Grattan RM Barr RK Winkelmann MW Greaves The pathogenesis of chronic idiopathic urticaria: new evidence suggests an auto-immune basis and implications for treatment Clin Exp Allergy 24 1994 624 627
31. TJ Lawley L Bielory P Gascon KB Yancey NS Young MM Frank A prospective clinical and immunologic analysis of patients with serum sickness N Engl J Med 311 1984 1407 1413
32. AA Hebert ES Sigman ML Levy Serum sickness–like reactions from cefaclor in children J Am Acad Dermatol 25 1991 805 808
33. N Lowery GL Kearns RA Young JG Wheeler Serum sickness–like reactions associated with cefprozil therapy J Pediatr 125 1994 325 328
34. LR Levine Quantitative comparison of adverse reactions to cefaclor vs. amoxicillin in a surveillance study Pediatr Infect Dis 4 1985 358 361
35. SR Heckbert WS Stryker KL Coltin JE Manson R Platt Serum sickness in children after antibiotic exposure: estimates of occurrence and morbidity in a health maintenance organization population Am J Epidemiol 132 1990 336 342
36. R Platt MW Dreis DL Kennedy JN Kuritsky Serum sickness–like reactions to amoxicillin, cefaclor, cephalexin, and trimethoprim-sulfamethoxazole J Infect Dis 158 1988 474 477
37. PM Peloso C Baillie Serum sickness–like reaction with bupropion [letter] JAMA 282 1999 1817
38. L Harel J Amir E Livni R Straussberg I Varsano Serum-sickness–like reaction associated with minocycline therapy in adolescents Ann Pharmacother 30 1996 481 483
39. C Vidal Pan A Gonzalez Quintela Doxycycline-induced parotitis [letter] Postgrad Med J 67 1991 313 314
40. SR Knowles L Shapiro NH Shear Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature Arch Dermatol 132 1996 934 939
41. GL Kearns JG Wheeler SH Childress LG Letzig Serum sickness–like reactions to cefaclor: role of hepatic metabolism and individual susceptibility J Pediatr 125 1994 805 811
42. NH Shear M Landau LE Shapiro Hypersensitivity reactions to drugs JOA Harper N Prose Textbook of pediatric dermatology Vol 2 2000 Blackwell Science London 1743 1752
43. GL Kearns JG Wheeler MJ Rieder J Reid Serum sickness–like reaction to cefaclor: lack of in vitro cross-reactivity with loracarbef Clin Pharmacol Ther 63 1998 686 693
44. JG Morelli YK Tay M Rogers A Halbert B Krafchik WL Weston Fixed drug eruptions in children J Pediatr 134 1999 365 367
45. KB Mohamed Fixed drug eruption associated with co-trimoxazole J Pediatr 135 1999 396
46. E Ozkaya-Bayazit H Bayazit G Ozarmagan Drug related clinical pattern in fixed drug eruption Eur J Dermatol 10 2000 288 291
47. A Mahboob TS Haroon Drugs causing fixed eruptions: a study of 450 cases Int J Dermatol 37 1998 833 838
48. AJ Kanwar SC Bharija M Singh MS Belhaj Ninety-eight fixed drug eruptions with provocation tests Dermatologica 177 1988 274 279
49. JM Leventhal D Griffin KO Duncan S Starling CW Christian T Kutz Laxative-induced dermatitis of the buttocks incorrectly suspected to be abusive burns Pediatrics 107 2001 178 179
50. AJ Kanwar S Dhar S Ghosh S Kaur Mucosal fixed drug eruption [letter] Dermatology 188 1994 171
51. VK Sharma S Dhar AN Gill Drug related involvement of specific sites in fixed eruptions: a statistical evaluation J Dermatol 23 1996 530 534
52. TP Thankappan J Zachariah Drug-specific clinical pattern in fixed drug eruptions Int J Dermatol 30 1991 867 870
53. S Brown Fixed eruption in deeply pigmented subjects: clinical observations in 350 patients BMJ 2 1964 1041 1044
54. WB Shelley ED Shelley Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline J Am Acad Dermatol 17 1987 403 407
55. U Hindioglu S Sahin Nonpigmenting solitary fixed drug eruption caused by pseudoephedrine hydrochloride J Am Acad Dermatol 38 1998 499 500
56. AJ Kanwar SC Bharija MS Belhaj Fixed drug eruptions in children: a series of 23 cases with provocative tests Dermatologica 172 1986 315 318
57. BJ Baird RL De Villez Widespread bullous fixed drug eruption mimicking toxic epidermal necrolysis Int J Dermatol 27 1988 170 174
58. AY Lee Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years Contact Dermatitis 38 1998 258 260
59. M Hindsen OB Christensen V Gruic H Lofberg Fixed drug eruption: an immunohistochemical investigation of the acute and healing phase Br J Dermatol 116 1987 351 360
60. R Pellicano A Silvestris M Iannantuono G Ciavarella M Lomuto Familial occurrence of fixed drug eruptions Acta Derm Venereol 72 1992 292 293
61. J Hatzis K Noutsis E Hatzidakis K Bassioukas A Perissios Fixed drug eruption in a mother and her son Cutis 50 1992 50 52
62. R Pellicano G Ciavarella M Lomuto G Di Giorgio Genetic susceptibility to fixed drug eruption: evidence for a link with HLA-B22 J Am Acad Dermatol 30 1994 52 54
63. H Lim Abnormal responses to ultraviolet radiation: photosensitivity induced by exogenous agents IMEA Freedberg K Wolff KF Austen LA Goldsmith SI Katz TB Fitzpatrick Dermatology in general medicine Vol 1 1999 McGraw-Hill New York 1589 1597
64. KP Mathews Clinical spectrum of allergic and pseudoallergic drug reactions J Allergy Clin Immunol 74 1984 558 566
65. IE Kochevar Basic principles in photomedicine and photochemistry HW Lim NA Soter Clinical photomedicine 1993 M. Dekker New York 1 18
66. DD Marc Farlane VA DeLeo Phototoxic and photoallergic dermatitis J Gum Practical contact dermatitis 1995 McGraw-Hill, Inc New York 83 92
67. P Tennis RS Stern Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study Neurology 49 1997 542 546
68. MA Gennis R Vemuri EA Burns JV Hill MA Miller SP Spielberg Familial occurrence of hypersensitivity to phenytoin Am J Med 91 1991 631 634
69. DK Chang NH Shear Cutaneous reactions to anticonvulsants Semin Neurol 12 1992 329 337
70. JW Taylor MN Stein MJ Murphy FA Mitros Cholestatic liver dysfunction after long-term phenytoin therapy Arch Nemol 41 1984 500 501
71. CC Vittorio JJ Muglia Anticonvulsant hypersensitivity syndrome Arch Intern Med 155 1995 2285 2290
72. RS Kleier DL Breneman S Boiko Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome Arch Dermatol 127 1991 1361 1364
73. J Stanley V Fallon-Pellicci Phenytoin hypersensitivity reaction Arch Dermatol 114 1978 1350 1353
74. RC Staughton CM Payne JI Harper H McMichen Toxic pustuloderma-a new entity? J R Soc Med 77 1984 6 8
75. S Bastuji-Garin B Rzany RS Stern NH Shear L Naldi JC Roujeau Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme Arch Dermatol 129 1993 92 96
76. EF Sherertz BV Jegasothy GS Lazarus Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid ″pulse therapy” J Am Acad Dermatol 12 1985 178 181
77. E Haruda Phenytoin hypersensitivity: 38 cases Neurology 29 1979 1480 1485
78. BHGB Chaiken JP Segal Dilantin hypersensitivity: report of a case of hepatitis with jaundice, pyrexia, and exfoliative dermatitis N Engl J Med 242 1950 897 898
79. AR Morkunas MB Miller Anticonvulsant hypersensitivity syndrome Crit Care Clin 13 1997 727 739
80. SR Knowles AK Gupta NH Shear D Sander Azathioprine hypersensitivity-like reactions-a case report and a review of the literature Clin Exp Dermatol 20 1995 353 356
81. E Meys JP Devogelaer A Geubel J Rahier C Nagant de Deuxchaisnes Fever, hepatitis and acute interstitial nephritis in a patient with rheumatoid arthritis. Concurrent manifestations of azathioprine hypersensitivity J Rheumatol 19 1992 807 809
82. JR Michael WE Mitch Reversible renal failure and myositis caused by phenytoin hypersensitivity JAMA 236 1976 2773 2775
83. J Harney MR Glasberg Myopathy and hypersensitivity to phenytoin Neurology 33 1983 790 791
84. BL Cohen GJ Bovasso Leukopenia as an unusual component of diphenylhydantoin hypersensitivity. A case with pruritus, rash, fever, lymphadenopathy, but low leukocyte count Clin Pediatr (Phila) 12 1973 622 623
85. SH Josephs SJ Rothman RH Buckley Phenytoin hypersensitivity [clinical conference] J Allergy Clin Immunol 66 1980 166 172
86. IC Guerra WAT Fawcett AH Redmon EC Lawrence HM Rosenblatt WT Shearer Permanent intrinsic B cell immunodeficiency caused by phenytoin hypersensitivity J Allergy Clin Immunol 77 1986 603 607
87. K Ray-Choudhury IF Pye M Boggild Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure Neurology 39 1989 436 438
88. AK Silverman J Fairley RC Wong Cutaneous and immunologic reactions to phenytoin J Am Acad Dermatol 18 1988 721 741
89. A Gupta MC Eggo JP Uetrecht AE Cribb D Daneman MJ Rieder Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides Clin Pharmacol Ther 51 1992 56 67
90. NH Shear SP Spielberg Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk J Clin Invest 82 1988 1826 1832
91. TS Brown JE Appel JS Kasteler JP Callen Hypersensitivity reaction in a child due to lamotrigine Pediatr Dermatol 16 1999 46 49
92. AH Guberman FM Besag MJ Brodie JM Dooley MS Duchowny JM Pellock Lamotrigine-associated rash: risk/benefit considerations in adults and children [see comments] Epilepsia 40 1999 985 991
93. S Knowles T Choudhury NH Shear Metronidazole hypersensitivity Ann Pharmacother 28 1994 325 326
94. SR Knowles J Uetrecht NH Shear Idiosyncratic drug reactions: the reactive metabolite syndromes [In Process Citation] Lancet 356 2000 1587 1591
95. AK Gupta JB Kopstein NH Shear Hypersensitivity reaction to terbinafine J Am Acad Dermatol 36 1997 1018 1019
96. H Gleichmann Studies on the mechanism of drug sensitization: T-cell–dependent popliteal lymph node reaction to diphenylhydantoin Clin Immunol Immunopathol 18 1981 203 211
97. MJ Rieder NH Shear A Kanee BK Tang SP Spielberg Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions Clin Pharmacol Ther 49 1991 13 17
98. S Chopra NJ Levell G Cowley JJ Gilkes Systemic corticosteroids in the phenytoin hypersensitivity syndrome Br J Dermatol 134 1996 1109 1112
99. P Wolkenstein J Latarjet JC Roujeau C Duguet S Boudeau L Vaillant Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis Lancet 352 1998 1586 1589
100. E Schopf A Stuhmer B Rzany N Victor R Zentgraf JF Kapp Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany Arch Dermatol 127 1991 839 842
101. JC Huff WL Weston MG Tonnesen Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes J Am Acad Dermatol 8 1983 763 775
102. S Hurwitz Erythema multiforme: a review of its characteristics, diagnostic criteria, and management Pediatr Rev 11 1990 217 222
103. WJ Dikland AP Oranje E Stolz T van Joost Erythema multiforme in childhood and early infancy Pediatr Dermatol 3 1986 135 139
104. CM Ginsburg Stevens-Johnson syndrome in children Pediatr Infect Dis 1 1982 155 158
105. WW Howland LE Golitz WL Weston JC Huff Erythema multiforme: clinical, histopathologic, and immunologic study J Am Acad Dermatol 10 1984 438 446
106. C Leaute-Labreze T Lamireau D Chawki J Maleville A Taieb Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome Arch Dis Child 83 2000 347 352
107. JS Prendiville AA Hebert MJ Greenwald NB Esterly Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children J Pediatr 115 1989 881 887
108. HL Chan RS Stern KA Arndt J Langlois SS Jick H Jick The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients Arch Dermatol 126 1990 43 47
109. MG Stewart NO Duncan DJ Franklin EM Friedman M Sulek Head and neck manifestations of erythema multiforme in children Otolaryngol Head Neck Surg 111 1994 236 242
110. MI Arstikaitis Ocular aftermath of Stevens-Johnson syndrome Arch Ophthalmol 90 1973 376 379
111. RJ Hawk JS Storer RS Daum Toxic epidermal necrolysis in a 6-week-old infant Pediatr Dermatol 2 1985 197 200
112. MC Scully IJ Frieden Toxic epidermal necrolysis in early infancy J Am Acad Dermatol 27 1992 340 344
113. M Ringheanu TA Laude Toxic epidermal necrolysis in children-an update Clin Pediatr (Phila) 39 2000 687 694
114. JE Rasmussen Toxic epidermal necrolysis. A review of 75 cases in children Arch Dermatol 111 1975 1135 1139
115. J Goens M Song P Fondu D Blum G Achten Haematological disturbances and immune mechanisms in toxic epidermal necrolysis Br J Dermatol 114 1986 255 259
116. A Lyell Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal Br J Dermatol 100 1979 69 86
117. AB Ackerman NS Penneys WH Clark Erythema multiforme exudativum: distinctive pathological process Br J Dermatol 84 1971 554 566
118. RJ Margolis MG Tonnesen TJ Harrist AK Bhan BU Wintroub MC Mihm Jr Lymphocyte subsets and Langerhans cells/indeterminate cells in erythema multiforme J Invest Dermatol 81 1983 403 406
119. JC Roujeau TN Huynh C Bracq JC Guillaume J Revuz R Touraine Genetic susceptibility to toxic epidermal necrolysis Arch Dermatol 123 1987 1171 1173
120. J Revuz JC Roujeau JC Guillaume D Penso R Touraine Treatment of toxic epidermal necrolysis. Creteil`s experience Arch Dermatol 123 1987 1156 1158
121. T Kakourou D Klontza F Soteropoulou C Kattamis Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children Eur J Pediatr 56 1997 90 93
122. JE Rasmussen Erythema multiforme in children. Response to treatment with systemic corticosteroids Br J Dermatol 95 1976 181 186
123. GC Chaidemenos F Chrysomallis K Sombolos O Mourellou D Ioannides M Papakonstantinou Plasmapheresis in toxic epidermal necrolysis Int J Dermatol 36 1997 218 221
124. C Paul P Wolkenstein H Adle J Wechsler HJ Garchon J Revuz Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis Br J Dermatol 134 1996 710 714
125. I Viard P Wehrli R Bullani P Schneider N Holler D Salomon Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 282 1998 490 493
126. RSR Sarkar RV Koranne K Sardana Erythroderma in children: a clinico-etiological study J Dermatol 26 1999 507 511
127. ABC Pruszkowski S Fraitag D Teillac-Hamel JC Amoric Yves de Prost Neonatal and infantile erythrodermas Arch Dermatol 136 2000 875 880
128. STY Kucukguclu H Ozkan H Guven A Uguz F Maltepe Multiple-dose activated charcoal in an accidental vancomycin overdose J Toxicol Clin Toxicol 34 1996 83 86
129. MDF Cadoz T Guerma M Prince-David I Diop Mar Bacteriological, pharmacological and clinical comparison between amoxycillin and ceftriaxone in the treatment of 300 purulent meningitis Pathol Biol (Paris) 30 1982 522 525
130. PH Hoeger JI Harper Neonatal erythroderma: differential diagnosis and management Arch Dis Child 79 1998 186 191
131. SD Calobrisi BA Drolet NB Esterly Petechial eruption after the application of EMLA cream Pediatrics 101 1998 471 473
132. L Ohlsen S Englesson H Evers An anaesthetic lidocaine/prilocaine cream (EMLA) for epicutaneous application tested for cutting split skin grafts Scand J Plast Reconstr Surg 19 1985 201 209
133. FB de Waard-van der Spek GM van den Berg AP Oranje EMLA cream: an improved local anesthetic. Review of current literature Pediatr Dermatol 9 1992 126 131
134. E Gourrier A El Hanache P Karoubi G Mouchnino S Merbouche J Leraillez Problèmes cutanÉs après application d`EMLA chez prematures Arch Pediatr 3 1996 289 290
135. L Juhlin O Rollman Vascular effects of a local anesthetic mixture in atopie dermatitis Acta Derm Venereol 64 1984 439 440
136. I Rosdahl B Edmar H Gisslen P Nordin S Lillieborg Curettage of molluscum contagiosum in children: analgesia by topical application of a lidocaine/prilocaine cream (EMLA) Acta Derm Venereol 68 1988 149 153
137. MA Fung TG Berger A prospective study of acute-onset steroid acne associated with administration of intravenous corticosteroids Dermatology 200 2000 43 44
138. G Plewig AM Kligman Induction of acne by topical steroids Arch Dermatol Forsch 247 1973 29 52
139. B Monk WJ Cunliffe AM Layton DJ Rhodes Acne induced by inhaled corticosteroids Clin Exp Dermatol 18 1993 148 150
140. R Latif TA Laude Steroid acne in a 14-month-old boy Cutis 29 1982 373 374 376
141. RM Hurwitz Steroid acne J Am Acad Dermatol 21 1989 1179 1181
142. LK Cohen W George R Smith Isoniazid-induced acne and pellagra. Occurrence in slow inactivators of isoniazid Arch Dermatol 109 1974 377 381
143. CM Papa Acne and hidden iodides [letter] Arch Dermatol 112 1976 555 556
144. CL Kiraly M Alen J Korvola M Horsmanheimo The effect of testosterone and anabolic steroids on the skin surface lipids and the population of Propionibacteria acnes in young postpubertal men Acta Derm Venereol 68 1988 21 26
145. R Greenwood PB Fenwick WJ Cunliffe Acne and anticonvulsants Br Med J (Clip Res Ed) 287 1983 1669 1670
146. G Plewig JE Fulton AM Kligman Pomade acne Arch Dermatol 101 1970 580 584
147. E Finkelstein A Lazarov M Cagnano S Halevy Oil acne: successful treatment with isotretinoin J Am Acad Dermatol 30 1994 491 492
148. HI Remmer WE Falk Successful treatment of lithium-induced acne [letter] J Clin Psychiatry 47 1986 48
149. T Kakourou P Drosatou F Psychou K Aroni P Nicolaidou Erythema nodosum in children: a prospective study J Am Acad Dermatol 44 2001 17 21
150. L Labbe Y Perel J Maleville A Taieb Erythema nodosum in children: a study of 27 patients Pediatr Dermatol 13 1996 447 450
151. H Gordon Erythema nodosum Br J Dermatol 73 1961 393 409
152. SM Suarez AS Paller Plantar erythema nodosum: cases in two children Arch Dermatol 129 1993 1064 1065
153. WL Weston Diseases of the dermis and the subcutaneous tissues: erythema nodosum LA Schachner Pediatric dermatology 1988 Churchill Livingstone New York 849 851
154. PC Goldsmith MM Black Erythema nodosum and other forms of panniculitis J Harper A Orange N Prose Textbook of pediatric dermatology Vol 1 2000 Blackwell Science Oxford 616 627
155. S Doxiadis Erythema nodosum in children Medicine 30 1951 283 334
156. SL Soon RI Crawford Recurrent erythema nodosum associated with echinacea herbal therapy J Am Acad Dermatol 44 2001 298 299
157. BB Tan JT Lear AG Smith Acne fulminans and erythema nodosum during isotretinoin therapy responding to dapsone Clin Exp Dermatol 22 1997 26 27
158. E Daw Recurrent erythema nodosum of pregnancy Br Med J 2 1971 44
159. HP Baden FD Holcomb Erythema nodosum from oral contraceptives Arch Dermatol 98 1968 634 635
160. MA Salvatore PJ Lynch Erythema nodosum, estrogens, and pregnancy Arch Dermatol 116 1980 557 558
161. M Kibel Erythema nodosum in children S Afr Med J 44 1970 873 876
162. CW Lehman Control of chronic erythema nodosum with naproxen Cutis 26 1980 66 67
163. TDK Horio H Okamoto Y Miyachi S Imamura Potassium iodide in erythema nodosum and erythematous dermatoses J Am Acad Dermatol 9 1983 77 81
164. ML Levy KS Barron A Eichenfield PJ Honig Naproxen-induced pseudoporphyria: a distinctive photodermatitis J Pediatr 117 1990 660 664
165. R Allen M Rogers I Humphrey Naproxen induced pseudoporphyria in juvenile chronic arthritis J Rheumatol 18 1991 893 896
166. BA Lang LA Finlayson Naproxen-induced pseudoporphyria in patients with juvenile rheumatoid arthritis J Pediatr 124 1994 639 642
167. S Al-Khenaizan JF Schechter D Sasseville Pseudoporphyria induced by propionic acid derivatives J Cutan Med Surg 3 1999 162 166
168. B Taylor Pseudoporphyria from nonsteroidal anti-inflammatory drugs N Z Med J 100 1987 322 323
169. DA Birkett M Garretts CJ Stevenson Phototoxic bullous eruptions due to nalidixic acid Br J Dermatol 81 1969 342 344
170. JN Burry JR Lawrence Phototoxic blisters from high frusemide dosage Br J Dermatol 94 1976 495 499
171. JHTD Epstein JS Seibert WL Epstein Porphyria-like cutaneous changes induced by tetracycline hydrochloride photosensitization Arch Dermatol 112 1976 661 666
172. CA Riordan A Anstey F Wojnarowska Isotretinoin-associated pseudoporphyria Clin Exp Dermatol 18 1993 69 71
173. PMMJ Farr BL Diffey P Ince Skin fragility and blistering due to use of sunbeds Br Med 296 1988 1708 1709
174. JJ Green SM Manders Pseudoporphyria J Am Acad Dermatol 44 2001 1 9
175. EBC Harvey AS Paller EJ LaVoo W Hanna JW Balfe BR Krafchik Pseudoporphyria cutanea tarda: two case reports on children receiving peritoneal dialysis and erythropoietin therapy J Pediatr 121 1992 749 752
176. I Kochevar Phototoxicity of nonsteroidal inflammatory drugs Arch Dermatol 125 1989 824 826
177. JT Keane RW Pearson FD Malkinson Nalidixic acid-induced photosensitivity in mice: a model for pseudoporphyria J Invest Dermatol 82 1984 210 213
178. B Ljunggren Propionic acid-derived non-steroidal antiinflammatory drugs are phototoxic in vitro Photodermatol 2 1985 3 9
179. SRMK Checketts RD Baughman Nonsteroidal anti-inflammatory-induced pseudoporphyria: is there an alternative drug? Cutis 63 1999 223 225
180. KP Meadows CA Egan S Vanderhooft Acute generalized exanthematous pustulosis (AGEP), an uncommon condition in children: case report and review of the literature Pediatr Dermatol 17 2000 399 402
181. JC Roujeau P Bioulac-Sage C Bourseau JC Guillaume P Bernard C Lok Acute generalized exanthematous pustulosis. Analysis of 63 cases Arch Dermatol 127 1991 1333 1338
182. C Beylot P Bioulac MS Doutre Acute generalized exanthematic pustuloses (four cases)] (author`s transl Ann Dermatol Venereol 107 1980 37 48
183. R Yamasaki M Yamasaki Y Kawasaki R Nagasako Generalized pustular dermatosis caused by isoniazid [letter] Br J Dermatol 112 1985 504 506
184. DG Lambert S Dalac F Beer P Chavannet H Portier Acute generalized exanthematous pustular dermatitis induced by diltiazem [letter] Br J Dermatol 118 1988 308 309
185. A Kuchler H Hamm B Weidenthaler-Barth E Kampgen EB Brocker Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases Br J Dermatol 137 1997 808 811
186. A Moreau A Dompmartin B Castel B Remond D Leroy Drug-induced acute generalized exanthematous pustulosis with positive patch tests Int J Dermatol 34 1995 263 266
187. J Fayol P Bernard JM Bonnetblanc Pustular eruption following administration of cefazolin: a second case report [letter] J Am Acad Dermatol 19 1988 571
188. RE Kalb ME Grossman Pustular eruption following administration of cephradine Cutis 38 1986 58 60
189. KJ Macdonald CM Green KJ Kenicer Pustular dermatosis induced by co-trimoxazole Br Med J (Clin Res Ed) 293 1986 1279 1280
190. CA Commens GO Fischer Toxic pustuloderma following carbamazepine therapy [letter] Arch Dermatol 124 1988 178 179
191. RM Trueb G Burg Acute generalized exanthematous pustulosis due to doxycycline Dermatology 186 1993 75 78